AIM
IDXX icon

Achmea Investment Management’s Idexx Laboratories IDXX Stock Holding History

Achmea Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Sell
38,859
-2,898
-7% -$1.63M 0.51% 59
2026
Q1 		$23.5M Sell
41,757
-287
-0.7% -$184K 0.62% 49
2025
Q4 		$28.4M Buy
42,044
+24,275
+137% +$16.5M 0.73% 36
2025
Q3 		$11.4M Buy
17,769
+13,537
+320% +$8.22M 0.14% 157
2025
Q2 		$2.27M Buy
4,232
+2,117
+100% +$1.01M 0.03% 267
2025
Q1 		$888K Sell
2,115
-701
-25% -$304K 0.01% 337
2024
Q4 		$1.16M Sell
2,816
-15,974
-85% -$7.01M 0.02% 336
2024
Q3 		$9.49M Sell
18,790
-4,415
-19% -$2.14M 0.16% 165
2024
Q2 		$11.3M Buy
23,205
+1,111
+5% +$558K 0.2% 128
2024
Q1 		$11.9M Buy
22,094
+3,436
+18% +$1.88M 0.23% 119
2023
Q4 		$10.4M Sell
18,658
-2,299
-11% -$1.08M 0.21% 117
2023
Q3 		$9.16M Buy
20,957
+10,380
+98% +$5.18M 0.2% 121
2023
Q2 		$5.31M Buy
10,577
+6,195
+141% +$2.97M 0.11% 196
2023
Q1 		$2.19M Buy
4,382
+1,783
+69% +$853K 0.06% 290
2022
Q4 		$993K Sell
2,599
-2,987
-53% -$1.16M 0.03% 401
2022
Q3 		$1.82M Sell
5,586
-2,282
-29% -$838K 0.06% 288
2022
Q2 		$2.76M Buy
7,868
+550
+8% +$224K 0.09% 236
2022
Q1 		$4M Sell
7,318
-4,746
-39% -$2.5M 0.1% 224
2021
Q4 		$7.94M Sell
12,064
-3,911
-24% -$2.46M 0.38% 60
2021
Q3 		$9.94M Sell
15,975
-2,417
-13% -$1.62M 0.3% 88
2021
Q2 		$11.6M Sell
18,392
-1,654
-8% -$913K 0.4% 51
2021
Q1 		$9.81M Buy
20,046
+10,171
+103% +$5.1M 0.34% 71
2020
Q4 		$4.94M Buy
9,875
+8
+0.1% +$3.58K 0.18% 156
2020
Q3 		$3.88M Sell
9,867
-9,726
-50% -$3.6M 0.16% 167
2020
Q2 		$6.47M Sell
19,593
-657
-3% -$190K 0.22% 97
2020
Q1 		$4.91M Buy
20,250
+12,145
+150% +$3.17M 0.22% 99
2019
Q4 		$2.12M Buy
8,105
+554
+7% +$146K 0.08% 244
2019
Q3 		$2.05M Hold
7,551
– – 0.08% 248
2019
Q2 		$2.08M Sell
7,551
-3,803
-33% -$937K 0.08% 267
2019
Q1 		$2.54M Buy
11,354
+3,803
+50% +$785K 0.11% 207
2018
Q4 		$1.41M Sell
7,551
-3,399
-31% -$697K 0.06% 280
2018
Q3 		$2.73M Hold
10,950
– – 0.1% 228
2018
Q2 		$2.39M Hold
10,950
– – 0.08% 258
2018
Q1 		$2.1M Sell
10,950
-1,819
-14% -$336K 0.07% 283
2017
Q4 		$2M Buy
12,769
+7,048
+123% +$1.11M 0.07% 299
2017
Q3 		$889K Sell
5,721
-1,896
-25% -$300K 0.05% 342
2017
Q2 		$1.23M Buy
7,617
+1,896
+33% +$308K 0.07% 305
2017
Q1 		$885K Buy
+5,721
New +$789K 0.04% 381

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Achmea Investment Management's IDXX Position: Q2 2026 in Review

Achmea Investment Management reduced its Idexx Laboratories (IDXX) stake by 6.9% in Q2 2026, selling an estimated $1.63M and leaving 38,859 shares worth $20.5M. The position accounts for 0.51% of the portfolio, ranked #59.

Achmea Investment Management first reported a position in IDXX in Q1 2017 and has held it in 38 quarters since. The position peaked at $28.4M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Achmea Investment Management held 38,859 shares of Idexx Laboratories worth $20.5M as of Q2 2026.
  • Achmea Investment Management sold 2,898 Idexx Laboratories shares in Q2 2026, an estimated $1.63M.
  • Idexx Laboratories made up 0.51% of Achmea Investment Management's portfolio in Q2 2026, its #59 holding.
  • Achmea Investment Management first reported a position in Idexx Laboratories in Q1 2017 and has held it in 38 quarters since.
  • Achmea Investment Management's Idexx Laboratories position peaked at $28.4M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.